Oricell Therapeutics
Develops next-generation cell therapies for oncology and immunology
$70MSeries C1
Role not disclosedlg
leading global healthcare fund
Activity from announced rounds
Activity in this selectionnh-investment-securities-f5fecacf
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $70M 1 disclosed · full round size, not this investor’s share